Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
Hamid Mithoowani, Michela Febbraro
Current Oncology (2022) Vol. 29, Iss. 3, pp. 1828-1839
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3474-3474
Open Access | Times Cited: 40
Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazeer Hasan, et al.
European Polymer Journal (2024) Vol. 206, pp. 112800-112800
Closed Access | Times Cited: 22
Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy
Chongzheng Yan, Y Liu, Zhao Guo-zhi, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2281-2297
Open Access | Times Cited: 16
Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer
Mihaela Boța, Lavinia Vlaia, Alex-Robert Jîjie, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 598-598
Open Access | Times Cited: 11
Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review
Juan Carlos Restrepo, Darly Martínez Guevara, Andrés Pareja López, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2338-2338
Open Access | Times Cited: 8
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 8
Interactions and communications in lung tumor microenvironment: Chemo/radiotherapy resistance mechanisms and therapeutic targets
Feng Yuan, Ying Jiang, Lin Yang, et al.
Journal of drug targeting (2025), pp. 1-33
Closed Access | Times Cited: 1
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
George Doumat, Darine Daher, Morgan Bou Zerdan, et al.
Current Oncology (2023) Vol. 30, Iss. 1, pp. 704-719
Open Access | Times Cited: 19
Performance of machine learning algorithms for lung cancer prediction: a comparative approach
Satya Prakash Maurya, Pushpendra Singh Sisodia, Rahul Mishra, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
A review on non-small cell lung cancer
Sunil Kumar Verma, Minakshi Pandey, R. P. Khare, et al.
Vacunas (2024) Vol. 25, Iss. 2, pp. 239-253
Closed Access | Times Cited: 6
circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)
Yifang Tang, Zheng-hua Liu, Lei-yi Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment
Ijeoma Theresa Achi, Paromita Sarbadhikary, Blassan P. George, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3433-3433
Open Access | Times Cited: 27
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
Yiftah Barsheshet, Tali Voloshin, Boris Brant, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14073-14073
Open Access | Times Cited: 22
Liposomes-enabled cancer chemoimmunotherapy
Lele Zhang, Jiangpei Shi, Mao‐Hua Zhu, et al.
Biomaterials (2024) Vol. 313, pp. 122801-122801
Closed Access | Times Cited: 4
Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control
Xianzhe Huang, Wenwei Chen, Yanyan Wang, et al.
Frontiers of Medicine (2025)
Closed Access
Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans
Donghui Liu, Qian Li, Yan Shu, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Open Access
The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
Jing Zhang, Zequn Wang, Xihua Wei, et al.
Current Research in Pharmacology and Drug Discovery (2025) Vol. 8, pp. 100212-100212
Open Access
Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review
Pinelopi Bosgana, Dimitrios Ampazis, Vasileios Vlachakos, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 145-145
Open Access
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer
Paul Hofman, Petros Christopoulos, Nicky D’Haene, et al.
Lung Cancer (2025), pp. 108107-108107
Closed Access
Association between airway microbiota and systemic inflammation markers in non-small cell lung cancer patients
Danhui Huang, QianNan Ren, Lingyan Xie, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Development and validation of a nomogram model for predicting lymph node metastasis in early non-small-cell lung cancer
Hao Xie, Chao Wang, Lin Ma, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 1, pp. 299-310
Closed Access
circDENND4C serves as a sponge for miR-200b to drive non-small cell lung cancer advancement by regulating MMP-9 expression
Yaming Lv, Lan Wang, Yunhui Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
Yaqing Liu, Ping Yu, Liubo Zhang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Development of Polymer-Based Fluorescent Nanocomposites for Synergistic Inhibition of Non-Small Cell Lung Cancer with Gefitinib
Hao Li, Jie Yang, Rongrong Sun, et al.
Journal of Fluorescence (2025)
Closed Access
Efficacy and toxicity of stereotactic radiotherapy combined with third-generation EGFR-TKIs and immunotherapy in patients with brain metastases from non-small cell lung cancer
Xiaoxuan Tao, Qichang Gao, Yiyang Chen, et al.
Strahlentherapie und Onkologie (2025)
Open Access
Page 1 - Next Page

Scroll to top